translate English to French: 3.1.4 Adventitious Agents Safety Evaluation All of the components used in the production of pegaptanib and pegaptanib sodium solution for injection comply with the EMEA Note for Guidance on Minimizing the Risk of Transmitting Animal Spongiform Encephalopathy Agents Via Human and Veterinary Medicinal Products, EMEA/410/01 (European Medicines Agency).
3.1.4 Évaluation de l'innocuité des agents adventices Tous les composants utilisés dans la production du pegaptanib et de la solution de pegaptanib sodium injectable sont conformes à l'E MEA Note for Guidance on Minimizing the Risk of Transmitting Animal Spongiform Encephalopathy Agents Via Human and Veterinary Medicinal Products, EMEA/410/01 (European Medicines Agency) (« Note explicative concernant la réduction du risque de transmission des agents des encéphalopathies spongiformes animales par les médicaments à usages humain et vétérinaire »).